Search Results
-
Studying neurodevelopmental disorders
Stanford Medicine research on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions.
-
Tachycardia unraveled
Researchers engineered stem cell-derived heart tissues to study how tachycardia affects the heart and to uncover the inner workings of our body’s engine.
-
Cancer neuroscience discoveries give hope
To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.
-
Drug boosts nerve growth, muscle strength
A drug that boosts strength in injured or aging mice restores connections between nerves and muscle and suggests ways to combat weakness in humans due to aging, injury or disease.
-
Jumble of autism genes categorized
Combining two cutting-edge technologies, researchers revealed the impact of a multitude of genes that are associated with neurodevelopmental disorders, including autism, but whose effects on human brain development were previously unknown.
-
Stem cell therapy with Alzheimer’s
In a Stanford Medicine study, scientists transplanted stem cells into mice and found reduction of brain abnormalities typical of Alzheimer’s disease.
-
Leaders pledge to address climate change
A roundtable at the White House on reducing the health care industry’s climate-warming emissions includes leaders from Stanford Medicine.
-
Antibody treatment rejuvenates stem cells
Old muscle stem cells express high levels of the cancer-associated molecule CD47. Blocking a pathway mediated by CD47 restored strength to old mice in a Stanford Medicine study.
-
Brain cell transplantation aids research
Lab-grown clusters of human brain cells integrate so well into young rats’ brains they enable researchers to study neurodevelopmental disorders’ molecular and circuit underpinnings.
-
Bioethicists support researchers
In the five decades since the emergence of recombinant DNA technology, researchers at Stanford Medicine have benefited from the close involvement of bioethics experts.